I agree and was thinking the same thing about HIV license partner being the beneficiary of these off-label sales. I would think that would encourage interested parties to act sooner rather than later, but not sure how they can control this once the wheel is set in motion for off label indications?
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.